Natera, Inc. (NTRA) vs Waters Corporation (WAT)

Natera, Inc. and Waters Corporation are both Diagnostics & Research companies. Natera, Inc. is the larger, with a market value of $59.2B against $42.3B — 1.4× the size. Natera, Inc. has negative trailing earnings, so its P/E is not meaningful; Waters Corporation trades at 108×. Waters Corporation grew revenue faster over the last twelve months: 52.5% against 37.8%. Waters Corporation has the higher net margin (3.59% vs −7.11%) and the higher return on invested capital (1.05% vs −22.3%). Across the 20 metrics below, Waters Corporation leads on 15 and Natera, Inc. on 5.

Valuation

Metric NTRA WAT Diagnostics & Research median
P/E n/m 107.97 33.95
P/S 21.84 9.18 4.87
P/B 32.45 2.81 3.12
Price to free cash flow 702.06 116.27 34.02
EV/EBITDA n/m 49.82 25.20
EV/Sales 21.57 10.11 5.66
Earnings yield (0.33%) 0.93% (1.75%)
Free cash flow yield 0.14% 0.86% (0.13%)

Profitability

Metric NTRA WAT Diagnostics & Research median
Gross margin 65.23% 50.89% 50.89%
Operating margin (10.70%) 7.10% (8.57%)
Net margin (7.11%) 3.59% (6.37%)
Free cash flow margin 3.11% 7.89% 0.00%
Return on equity (12.54%) 1.92% (2.92%)
Return on assets (8.71%) 1.13% (6.71%)
Return on invested capital (22.34%) 1.05% 0.00%

Growth

Metric NTRA WAT Diagnostics & Research median
Revenue growth (TTM) 37.82% 52.47% 7.69%
EPS growth (last fiscal year) 0.65% 0.47% —
Revenue growth, 5-year CAGR 42.61% 6.00% 7.40%
Net income growth, 5-year CAGR 0.00% 4.26% 0.00%

Health

Metric NTRA WAT Diagnostics & Research median
Debt to equity 0.04 0.32 0.11
Current ratio 3.00 1.86 2.02
Net debt to EBITDA 3.74 0.36 0.78

Dividend

Metric NTRA WAT Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio 0.00 0.00 0.00

Size

Metric NTRA WAT Diagnostics & Research median
Market cap 59.17b 42.28b 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack